These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2154438)

  • 1. Pharmacokinetics of azithromycin in rats and dogs.
    Shepard RM; Falkner FC
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():49-60. PubMed ID: 2154438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of azithromycin and their clinical significance.
    Lode H
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):807-12. PubMed ID: 1662623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of azithromycin after single oral dosing of experimental animals.
    Davila D; Kolacny-Babić L; Plavsić F
    Biopharm Drug Dispos; 1991 Oct; 12(7):505-14. PubMed ID: 1657238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of azithromycin in human serum and tissues.
    Foulds G; Shepard RM; Johnson RB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():73-82. PubMed ID: 2154441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension.
    Nahata MC; Koranyi KI; Gadgil SD; Hilligoss DM; Fouda HG; Gardner MJ
    Antimicrob Agents Chemother; 1993 Feb; 37(2):314-6. PubMed ID: 8383944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine.
    Wildfeuer A; Laufen H; Leitold M; Zimmermann T
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():51-6. PubMed ID: 8396097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of azithromycin in human tonsillar tissue.
    Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of azithromycin in human prostatic tissue.
    Foulds G; Madsen P; Cox C; Shepard R; Johnson R
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):868-71. PubMed ID: 1722460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin pharmacokinetics and penetration to lymph.
    Bergan T; Jørgensen NP; Olszewski W; Zhang Y
    Scand J Infect Dis Suppl; 1992; 83():15-21. PubMed ID: 1336891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-directed pharmacokinetics.
    Schentag JJ; Ballow CH
    Am J Med; 1991 Sep; 91(3A):5S-11S. PubMed ID: 1656743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of dose regimens of azithromycin .
    Foulds G; Johnson RB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():39-50. PubMed ID: 8396095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species.
    Bruzzese T; Rimaroli C; Bonabello A; Mozzi G; Ajay S; Cooverj ND
    Arzneimittelforschung; 2000 Jan; 50(1):60-71. PubMed ID: 10683718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin levels in plasma and gastric tissue, juice and mucus.
    Harrison JD; Jones JA; Morris DL
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):862-4. PubMed ID: 1662634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of azithromycin in patients with impaired hepatic function.
    Mazzei T; Surrenti C; Novelli A; Crispo A; Fallani S; Carlà V; Surrenti E; Periti P
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():57-63. PubMed ID: 8396098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, oral bioavailability and tissue distribution of azithromycin in cats.
    Hunter RP; Lynch MJ; Ericson JF; Millas WJ; Fletcher AM; Ryan NI; Olson JA
    J Vet Pharmacol Ther; 1995 Feb; 18(1):38-46. PubMed ID: 7752305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.